Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ANAB

AnaptysBio (ANAB)

AnaptysBio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANAB
DateTimeSourceHeadlineSymbolCompany
24/04/202423:00PR Newswire (US)Actym Therapeutics Appoints Thomas Smart as CEONASDAQ:ANABAnaptysBio Inc
12/03/202407:41Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANABAnaptysBio Inc
12/03/202407:36Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANABAnaptysBio Inc
12/03/202407:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
01/03/202401:15GlobeNewswire Inc.Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual MeetingNASDAQ:ANABAnaptysBio Inc
15/02/202402:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANABAnaptysBio Inc
15/02/202400:35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANABAnaptysBio Inc
01/02/202401:15GlobeNewswire Inc.Anaptys to Present at Guggenheim’s 6th Annual Biotechnology ConferenceNASDAQ:ANABAnaptysBio Inc
10/01/202411:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
10/01/202411:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
06/01/202409:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
06/01/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
06/01/202408:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
06/01/202408:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
06/01/202408:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
06/01/202408:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
06/01/202408:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
06/01/202408:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
28/11/202308:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
28/11/202308:15GlobeNewswire Inc.Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa PharmaceuticalsNASDAQ:ANABAnaptysBio Inc
08/11/202308:15GlobeNewswire Inc.Anaptys Named a BioSpace 2024 Best Places to Work WinnerNASDAQ:ANABAnaptysBio Inc
03/11/202307:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANABAnaptysBio Inc
03/11/202307:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
03/11/202307:15GlobeNewswire Inc.Anaptys Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ANABAnaptysBio Inc
02/11/202300:15GlobeNewswire Inc.Anaptys Announces Participation in November Investor ConferencesNASDAQ:ANABAnaptysBio Inc
26/10/202307:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
12/10/202300:15GlobeNewswire Inc.Anaptys to Present Phase 1 Data on ANB032, its BTLA Agonist Antibody, at the 32nd EADV CongressNASDAQ:ANABAnaptysBio Inc
11/10/202300:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
09/10/202323:43Dow Jones NewsAnaptys Sees Positive Trial Results for Imsidolimad Psoriasis TreatmentNASDAQ:ANABAnaptysBio Inc
09/10/202323:15GlobeNewswire Inc.Anaptys to Provide Overview of Rosnilimab, a PD-1 Agonist, at Virtual R&D Event on Wednesday, Oct. 25NASDAQ:ANABAnaptysBio Inc
 Showing the most relevant articles for your search:NASDAQ:ANAB